BlackRock Fund Advisors’s Biolase, Inc. BIOL Stock Holding History

BlackRock Fund Advisors’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$146K	Hold	8	–	–	﹤0.01%	3510
2016 Q3	$176K	Hold	8	–	–	﹤0.01%	3489
2016 Q2	$118K	Hold	8	–	–	﹤0.01%	3622
2016 Q1	$134K	Sell	8 -1	-11%	-$12.5K	﹤0.01%	3587
2015 Q4	$92K	Buy	9 +1	+13%	+$10.9K	﹤0.01%	3750
2015 Q3	$94K	Sell	8 -1	-11%	-$18.6K	﹤0.01%	3719
2015 Q2	$187K	Buy	9 +1	+13%	+$24.4K	﹤0.01%	3551
2015 Q1	$191K	Hold	8	–	–	﹤0.01%	3502
2014 Q4	$265K	Buy	8 +1	+14%	+$31.3K	﹤0.01%	3403
2014 Q3	$233K	Sell	7 -1	-13%	-$28.3K	﹤0.01%	3425
2014 Q2	$221K	Sell	8 -71	-90%	-$1.81M	﹤0.01%	3459
2014 Q1	$2.38M	Buy	79 +4	+5%	+$140K	﹤0.01%	3121
2013 Q4	$2.62M	Buy	75 +2	+3%	+$47.4K	﹤0.01%	3096
2013 Q3	$1.73M	Buy	73 +8	+12%	+$258K	﹤0.01%	3142
2013 Q2	$2.85M	Buy	+65	New	+$3.63M	﹤0.01%	3015

Other funds holding BIOL

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Teton Advisors Rye, New York $173M AUM 77.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock Fund Advisors's BIOL Position: Q4 2016 in Review

BlackRock Fund Advisors held its Biolase, Inc. (BIOL) position steady in Q4 2016 at 8 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #3510.

BlackRock Fund Advisors first reported a position in BIOL in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.85M in Q2 2013. 34 funds tracked by Wall St. Rank hold BIOL as of Q4 2016.

BlackRock Fund Advisors held 8 shares of Biolase, Inc. worth $146K as of Q4 2016.
BlackRock Fund Advisors left its Biolase, Inc. share count unchanged in Q4 2016.
Biolase, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3510 holding.
BlackRock Fund Advisors first reported a position in Biolase, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Biolase, Inc. position peaked at $2.85M in Q2 2013.
34 funds tracked by Wall St. Rank held Biolase, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.